Rosehip Seed Oil

1. INCI & CAS

INCI: Rosehip Seed Oil · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Rosehip Seed Oil is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Confirm the finished-formula level against the supplier TDS.

Refer to the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• If Rosehip Seed Oil appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Rosehip Seed Oil for the product in its final form.
• Verify the purchased Rosehip Seed Oil grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it does not qualify a finished product as a drug or OTC product with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; for oxidation-sensitive formulas, consider an airless or pump pack; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• Names Rosehip Seed Oil as a cosmetic ingredient on this SKU

• This product entry cannot substantiate therapeutic results, cure claims, or unverified certification claims.
• The available details for Rosehip Seed Oil cannot establish a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

The guide uses caprylic/capric triglyceride as a light oil for lotion, balm, and cleansing-oil formats.

3. Typical use levels (formulation guide)

• Lotions: 3–8% as a formulation guide.
• The guide range for cleansing oils and balms is 20–60% as a formulation guide.

Route Caprylic/Capric Triglyceride through the oil phase.

4. Regulatory sources & global compliance

• CosIng information about Caprylic/Capric Triglyceride does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Caprylic/Capric Triglyceride is used, to be assessed before release of the finished cosmetic.
• Match the selected Caprylic/Capric Triglyceride material to its supplier TDS and check the filing list for the market of sale.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; the note establishes neither drug approval nor OTC-monograph status with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; select packaging with the formula's oxidation sensitivity in mind; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• This guide frames Caprylic/Capric Triglyceride's cosmetic direction around light-triglyceride.

• The formulation note cannot substantiate claims of drug action or cure, or a product certification outside the supporting records.
• The available details for Caprylic/Capric Triglyceride does not support skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Typical use levels (formulation guide)

• The gel-creams use-level reference is 2–6%.
• Dry oils may use the guide range 10–30% for the formula.
• Balms may use the guide range 5–15% for the formula.

The guide places Squalane in the oil phase and calls for no high-shear wax processing.

4. Regulatory sources & global compliance

• A CosIng listing for Squalane provides ingredient information, not approval of a supplied grade or finished product.
• Regulation (EC) No 1223/2009 sets the requirement for a safety evaluation of the product containing Squalane as it will be marketed before the cosmetic is placed on the EU market.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; it does not establish drug approval or OTC-monograph status with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; review airless or pump options if oxidation presents a concern; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The ingredient record provides no basis for therapeutic effects, curative outcomes, or unsupported certification statements.
• The cosmetic guidance for Squalane offers no support for whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.